EMA Authorised: Apixaban Accord (apixaban) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency authorised Apixaban Accord (apixaban) from Accord Healthcare S.L.U. for indications in venous thromboembolism, stroke, and after a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Venous Thromboembolism

Drugs mentioned

• Apixaban Accord (apixaban)

Snippet

Status: Authorised. Therapeutic area: Venous Thromboembolism;Stroke;Arthroplasty. MAH: Accord Healthcare S.L.U.. Decision date: 24/02/2026